Management and Outcomes of Patients at a Specialty Clinic for Clostridioides difficile Infection

Aaron Hunt,Larry H. Danziger,Stuart Johnson,Andrew M. Skinner

OPEN FORUM INFECTIOUS DISEASES（2024）

引用 0|浏览6

暂无评分

摘要

Vancomycin and fidaxomicin taper regimens were the most common treatment strategies employed but nearly half of patients (40/83) referred to our Clostridioides difficile infection (CDI) clinic did not require further treatment. The overall 60-day CDI recurrence rate was 16.9% (11/65). CDI management at a dedicated clinic may improve clinical outcomes.

查看译文

关键词

bezlotoxumab,Clostridioides difficile,fidaxomicin,recurrent C. difficile infection,vancomycin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要